Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Omega-3 Supplementation to Reduce BronchopulmonarY Dysplasia in Very Preterm Infants (MOBYDIck Trial)

NCT02371460 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT02371460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Omega-3 Supplementation to Reduce BronchopulmonarY Dysplasia in Very Preterm Infants (MOBYDIck Trial)
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Phase 3
Overall status
Terminated
Start date
June 23, 2015
Completion date
July 7, 2023
Enrollment
461 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, child development, neonatal and perinatal conditions